ASK REDCHAT ANYTHING ABOUT ALTIMMUNE, INC.
Altimmune, Inc. (NASDAQ: ALT)
Listen to this Section
$2.71
-0.2090
(
-7.16% )
1.8M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Pemvidutide (ALT-801) (GLP-1R/GCGR)DetailsNon-alcoholic steatohepatitis , Non-Alcoholic Fatty Liver Disease, metabolic dysfunction-associated steatohepatitisBig Mover™Suspected Mover™Susp. Mover™ |
Phase 2b |
| Pemvidutide (ALT-801) (GLP-1R/GCGR)Detailsmetabolic dysfunction-associated steatohepatitis |
Phase 2b |
| Pemvidutide (ALT-801) (GLP-1R/GCGR)DetailsObesity |
Phase 2 |
| Pemvidutide (ALT-801) (GLP-1R/GCGR)DetailsType 2 diabetes |
Phase 1b |
| AdCOVIDDetailsCOVID-19 |
Failed |
| NasoShield (Vaccine)DetailsAnthrax, Bacterial infection |
Failed |
| HepTCellDetailsChronic hepatitis B |
Failed |
| T-COVIDDetailsCOVID-19 |
Failed |
| NasoVAXDetailsInfluenza |
Failed |
Market Data
|
| Open |
$2.71 |
| Previous Close |
$2.92 |
| Volume |
1.8M |
| Market Cap |
$558.14M |
| Day Range |
$2.71 - $2.97 |
| 52 Week Range |
$2.56 - $7.73 |
| Shares Outstanding |
194.47M |
| Change % |
-7.16% |
| Net Change |
▼ -0.2090 |
| Insider Ownership |
-0.05% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Year | 2005 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-1,445,994.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-08-01 |
Sale |
-1486.00 |
Harris Matthew Scott |
| 2024-08-01 |
Sale |
-1259.00 |
Shutterly Andrew |
| 2024-08-01 |
Sale |
-650.00 |
Roberts M Scot |
| 2024-08-01 |
Sale |
-917.00 |
Jordt Raymond M |
| 2024-02-05 |
Sale |
-6166.00 |
Roberts M Scot |
| 2024-02-05 |
Sale |
-16545.00 |
Garg Vipin K |
| 2024-02-05 |
Sale |
-6166.00 |
Harris Matthew Scott |
| 2024-02-01 |
Sale |
-5030.00 |
Jordt Raymond M |
| 2024-02-01 |
Sale |
-9275.00 |
Eisenstadt Richard I |
| 2024-02-01 |
Sale |
-26775.00 |
Garg Vipin K |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 4 |
Insider transactions |
1 |
Nov 12, 2025 |
| 8-k |
8K-related |
14 |
Nov 06, 2025 |
| 10-q |
Quarterly Reports |
62 |
Nov 06, 2025 |
| 8-k |
8K-related |
14 |
Nov 06, 2025 |
| 8-k |
8K-related |
12 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 3 |
Insider transactions |
2 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 4 |
Insider transactions |
2 |
Sep 29, 2025 |
| 4 |
Insider transactions |
1 |
Sep 29, 2025 |